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The prevalence of an abnormal signal-averaged electrocar-
diogram (ECG) and ventricular arrhythmias on 24 ham·
bulatory electrocardiography was evaluated in 118 patients
13 ± 2 days after acute myocardial infarction. Group 1 (46
patients) underwent intravenous thrombolysis within 6 h of
the onset of symptoms, whereas Group 2 (72 patients) did
not. An abnormal signal-averaged ECG was seen in 15% of
patients in Group 1and 21 %of those in Group 2(difference
not significant).
The number of ventricular premature complexes/h was
lower in Group 1 than in Group 2: 2.58 ± 1.63 versus 7.91
± 10.75 (p < 0.01). However, complex arrhythmias (~10
ventricular premature complexes/h or ventricular tachy-
cardia) were equally common in Groups 1 and 2 (20%
versus 22%, respectively). Their prevalence was similar in
Several major trials (l,2) have assessed the impact of throm-
bolysis on infarct size, as estimated by electrocardiographic
(ECG) and enzymatic criteria and by studies of left ventric-
ular function, as well as on prognosis after acute myocardial
infarction. In contrast, little is known about the influence of
thrombolysis on markers for electrical instability, namely,
late potentials on the signal-averaged ECG (3,4) and com-
plex ventricular arrhythmias on 24 h ambulatory electrocar-
diography (5,6). We conducted a prospective study to deter-
mine whether thrombolysis reduces the prevalence of late
potentials and complex ventricular arrhythmias by compar-
ing recordings of the signal-averaged and ambulatory ECGs
obtained in a series of patients treated with or without
intravenous thrombolysis for acute myocardial infarction.
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patients with or without an abnormal signal-averaged ECG
(29% versus 18%, respectively, in Group 1and 27% versus
21 %, respectively, in Group 2). Comparison between pa-
tients with (n = 26) or without (n = 20) angiographic
patency of the infarct-related coronary artery after throm-
bolysis showed no significant difference in the prevalence of
an abnormal signal-averaged ECG (8% versus 25%, re-
spectively) and complex ventricular arrhythmias (19% ver-
sus 20%, respectively).
These data suggest that thrombolysis does not affect the
prevalence of complex ventricular arrhythmias and an
abnormal signal-averaged ECG or their relation after acute
myocardial infarction.
(J Am Coli CardioI1990i15:1270-6)
Methods
Study patients. Patients were included in this study if
they fulfilled the following criteria: 1) a diagnosis of acute
myocardial infarction based on the presence of typical chest
pain for>30 min not relieved by sublingual nitrates, > 1 mm
of ST elevation in two or more adjacent leads on the
admission ECG, with subsequent development of Q waves
or persistent (>24 h) ST-T changes and an increase in serum
enzymes (creatine kinase and its MB isoenzyme); 2) absence
of prior myocardial infarction according to history and ECG;
3) QRS duration <120 ms, with absence of bundle branch
block pattern and QT prolongation on the 12 lead ECG; and
4) survival to completion of the protocol. A total of 118
consecutive patients admitted to our hospital between Jan-
uary and November 1989 met the inclusion criteria and
entered the study. Among them, 46 patients who were
hospitalized within 6 h of the onset of symptoms and without
contraindications to it received thrombolytic therapy by
intravenous route; the remaining 72 patients did not receive
this treatment because of their late hospital arrival (n = 67),
or the occurrence of cardiogenic shock (n = 2), prolonged
cardiopulmonary resuscitation (n = 1) or recent gastrointes-
tinal bleeding (n = 2). Agents used for intravenous throm-
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bolysis were urokinase (2 million U over 60 min) in 35
patients, streptokinase (1.5 million U over 60 min) in 4
patients and recombinant tissue-type plasminogen activator
(100 mg over 180 min) in 7 patients.
Study design. All patients had a 24 h ambulatory ECG
before discharge 13 ± 2 days after the index infarction and
after withdrawal of all therapy for 2'::24 h. No patients
received a beta-adrenergic blocker throughout the study
period. Except for 1 patient who developed recurrent sus-
tained ventricular tachycardia and was treated with amio-
darone after recording the signal-averaged and ambulatory
ECG, the only antiarrhythmic drug used during the study
was lidocaine, which was given to 14 patients during the first
5 days after infarction. The signal-averaged ECG was re-
corded within 24 h of the ambulatory ECG in all patients.
Signal-averaged ECG. Recordings were performed with
the Arrhythmia Research Technology model 1200 EPX unit
using previously reported techniques (7). The ECG was
recorded during sinus rhythm with standard bipolar orthog-
onal X, Y and Z leads. Signals were amplified, averaged and
filtered with a bidirectional filter at frequencies of 25 to 250
Hz. The filtered leads were combined into a vector magni-
tude ~X2+y2+Z2. A computer program algorithm deter-
mined the onset and offset of the QRS complex and calcu-
lated total QRS duration, duration of low amplitude signals
<40 ILV, root mean square voltage of the total QRS complex
and root mean square voltage of signals in the last 40 ms of
the QRS complex (RMS40). Recordings with a noise level
2':: 1 ILV were rejected. Between 200 and 400 complexes were
usually averaged to reach this end point noise level. An
abnormal signal-averaged ECG was defined as a recording
showing one or more of the following abnormalities: total
QRS duration> 115 ms, duration of low amplitude signals
>32 ms, root mean square voltage of signals in the last 40 ms
of the QRS complex <25 ILV (8). Late potentials were
defined as signals with abnormal root mean square voltage of
signals in the last 40 ms of the QRS complex.
Ambulatory ECG. A two channel, 24 h ECG was re-
corded with the Avionics model 445 portable unit and
analyzed with the Avionics model 660B replay unit. Arrhyth-
mia detection and interpretation were performed by three of
the investigators (G.T., A.L.R., E.Z.). The number and
configuration of ventricular premature complexes and the
prevalence of polymorphic ventricular premature com-
plexes, couplets, nonsustained ventricular tachycardia
(three or more ventricular premature complexes, lasting <30
s at a rate of > 100/min) and sustained ventricular tachycar-
dia (2'::30 s) were assessed. Complex ventricular arrhythmias
were defined as frequent ventricular premature complexes
(2':: lO/h) or ventricular tachycardia, or both (9).
Cardiac catheterization. All 46 patients subjected to
thrombolysis underwent cardiac catheterization 10 ± 5 days
after infarction. All had given written informed consent to an
ongoing protocol on the effects of thrombolysis, as approved
by our institution. In the group not treated with thromboly-
sis, 39 of the 72 patients underwent cardiac catheterization
12 ± 4 days after infarction because of the presence of early
postinfarction angina (n = 8), left ventricular failure (n = 3),
non-Q wave myocardial infarction (n = 12) or at the request
of their attending physician (n = 16). Selective coronary
angiograms were recorded in multiple views; the left ven-
triculogram was recorded in the right anterior oblique view.
Left ventricular ejection fraction was calculated according to
the area-length method. Left ventricular wall motion abnor-
malities, defined as the presence of segmental akinesia or
dyskinesia, were evaluated using a five segment model that
divided the ventricular outline into anterobasal, anterolat-
eral, apical, inferior and posterobasal segments (10).
ECG location of myocardial infarction. This was related
to coronary anatomy and left ventricular wall motion as
follows (11-14):
Anterior infarction (including anterior, anteroseptal, an-
terolateral and lateral locations on the 12 lead ECG) was
related to disease in the left anterior descending coronary
artery and wall motion abnormalities in the anterobasal,
anterolateral and apical segments.
Inferior infarction (including inferior, inferoposterior,
posterior and inferolaterallocations on the 12 lead ECG) was
related to disease in the circumflex or right coronary artery
and wall motion abnormalities in the inferior and poster-
obasal segments.
Definitions. The following definitions were adopted:
Successful thromholysis: patency of the infarct-related
coronary artery with grade 2'::2 flow in the Thrombolysis in
Myocardial Infarction trial classification (14).
Collateral circulation: opacification of the artery distal to
a stenotic or occluded segment by branches from other
major coronary arteries (modified by Elayda et al. [15]).
Statistical analysis. Patients were separated into two
groups according to whether they did or did not receive
intravenous thrombolytic therapy. Group 1 consisted of
patients subjected to thrombolysis, and was further divided
into two subgroups based on the success (Group lA) or
failure (Group IB) of thrombolysis. Group 2 included pa-
tients who did not undergo thrombolysis. Patients from both
groups characterized by patency or occlusion of the infarct-
related coronary artery were pooled together for further
analysis. Student's t test and chi-square analysis, with
Yates' correction for continuity or Fisher's exact test where
appropriate, were used for comparisons. A p value <0.05
was considered statistically significant. Continuous variables
were expressed as mean values ± 1 SD.
Results
Comparison of patients with or without thrombolysis (Ta-
ble 1). Patients who received thrombolysis (Group I) were
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Table 1. Characteristics of 118 Patients With or Without Thrombolysis During Acute
Myocardial Infarction
Thrombolysis No Thrombolysis
(n = 46) (n = 72) p Value
Clinical data
Age (yr) 53 :t 10 59 ± 10 NS
Male/female 10/36 16/56 NS
Time from onset of symptoms to 2.6 :t 1.4 12.6 ± 7.8 <0.0001
hospitalization (h)
Anterior MI (%) 20 (43) 38 (53) NS
Non-Q wave MI (%) 5(11) 12 (17) NS
Peak CK (IU/liter) 2340 :t 1445 2281 ± 2004 NS
Peak MB CK (IU/liter) 253 :t 129 279 ± 197 NS
VF 0-5 days after MI (%) 3 (7) 5(7) NS
Ambulatory ECG data
VPCs/h (n) 2.58 ± 1.63 7.91 ± 10.75 <0.01
Frequent VPCs (%) 4 (9) 14 (19) NS
Polymorphic VPCs (%) 7 (15) 14 (19) NS
Couplets (%) 2 (4) 3 (5) NS
Nonsustained VT (%) 6 (13) 7 (10) NS
Sustained VT (%) 0 I (I) NS
Complex ventricular arrhythmias (%) 9 (20) 16 (22) NS
Signal-averaged ECG data
QRS duration (ms) 101 :t 12 103 ± 18 NS
LAS40 (ms) 26 :t II 26 ± 15 NS
RMS QRS (IlV) 118 :t 44 130 ± 46 NS
RMS40 (j.LV) 61 ± 39 59 ± 39 NS
Prolonged QRS duration (%) 4 (9) 12 (17) NS
Prolonged LAS40 (%) 7 (15) 13 (18) NS
Late potentials (%) 7 (15) 12 (17) NS
Abnormal signal-averaged ECG (%) 7 (15) IS (21) NS
I abnormal variable (%) 7 (15) IS (21) NS
2 abnormal variables (%) 7 (15) 13 (18) NS
3 abnormal variables (%) 4 (19) 9 (13) NS
Continuous variables are expressed as mean values ± SO; CK =creatine kinase; MB CK = creatine kinase-MB
isoenzyme; ECG = electrocardiographic; LAS40 = duration of low amplitude signals <40 j.LV; MI = myocardial
infarction; RMS QRS =root mean square voltage of the total QRS complex; RMS40 =root mean square voltage of
last 40 ms of the QRS complex; VF = ventricular fibrillation; VPCs = ventricular premature complexes; VT =
ventricular tachycardia.
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not significantly different from patients who did not (Group
2) with regard to age, gender distribution, type and location
of myocardial infarction, maximal increase in serum cardiac
enzymes and prevalence of ventricular fibrillation during
hospitalization. An abnormal signal-averaged ECG was re-
corded in 22 (19%) of the 118 study patients, with no
significant difference between Groups I and 2 (15% versus
21%, respectively). No significant differences were found
between Groups I and 2 in terms of the prevalence of
prolonged QRS duration, prolonged low amplitude signal
duration and late potentials, singly or in combination, or the
mean value of any of the signal-averaged ECG variables. An
abnormal signal-averaged ECG was slightly more frequent in
patients with inferior than anterior infarction (19% versus
10% in Group 1and 24% versus 18% in Group 2, respective-
ly), However, comparison of the signal-averaged ECG data
according to the site of infarction did not reveal any signif-
icant differences between groups.
Complex ventricular arrhythmias on the ambulatory ECG
were observed in 25 (21%) of the 118 study patients, with no
significant difference between Groups I and 2 (20% versus
22%, respectively). No significant differences were found
between Groups I and 2 in terms of the prevalence of any of
the index arrhythmias (frequent, polymorphic or repetitive
ventricular premature complexes or ventricular tachycar-
dia). However, the mean hourly number of ventricular
premature complexes was lower in Group 1 than in Group 2
(p < 0.01). Complex ventricular arrhythmias were equally
common in patients with or without an abnormal signal-
averaged ECG in both groups. In fact, they were present in
29% of patients in Group I and 27% of patients in Group 2
who had an abnormal signal-averaged ECG, as well as in
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Table 2. Characteristics of 46 Patients Undergoing Thrombolysis With or Without Success During
Acute Myocardial Infarction
Successful No Successful
Thrombolysis Thrombolysis
(n = 26) (n = 20) p Value
Angiographic data
Ejection fraction 0.62 :to 0.13 0.54 ± 0.12 <0.05
Aldyskinesia in infarcted segment(s) (%) 8(31) 17 (85) <0.001
Collateral circulation to 4 (15) 16 (80) <0.001
infarct-related artery (%)
Ambulatory ECG data
VPCs/h (n) 1.11 ± 0.88 4.49 ± 2.61 <0.01
Frequent VPCs (%) 1(4) 3 (15) NS
Polymorphic VPCs (%) 4 (15) 3 (15) NS
Couplets (%) 0 2 (10) NS
Nonsustained VT (%) 4 (15) 2 (10) NS
Complex ventricular arrhythmias (%) 5 (19) 4 (20) NS
Signal-averaged ECG data
QRS duration (ms) 99 ± 13 106 ± 13 NS
LAS40 (ms) 23 ± II 29 ± 12 NS
RMS QRS (/LV) 136 ± 51 94 ± 32 <0.01
RMS40 (/LV) 73 ± 50 45 :to 25 <0.05
Prolonged QRS duration (%) 1 (4) 3 (15) NS
Prolonged LAS40 (%) 2 (8) 5 (25) NS
Late potentials (%) 2 (8) 5 (25) NS
Abnormal signal-averaged ECG (%) 2 (8) 5 (25) NS
1 abnormal variable (%) 2 (8) 5 (25) NS
2 abnormal variables (%) 2 (8) 5 (25) NS
3 abnormal variables (%) 1(4) 3 (15) NS
A = akinesia; other abbreviations as in Table 1.
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18% of patients in Group 1 and 21% of patients in Group 2
who had a normal signal-averaged ECG. These differences
were not statistically significant.
Comparison of patients with or without successful throm-
bolysis (Table 2). Thrombolysis was successful in restoring
patency of the infarct-related coronary artery in 26 patients
(Group lA), but failed to do so in 20 patients (Group lB).
Left ventricular ejection fraction was higher (p < 0.05),
whereas akinesia or dyskinesia in the infarcted area and
collateral circulation to the infarct-related vessel were less
common (p < 0.001) in the presence (Group lA) than in the
absence (Group IB) of successful thrombolysis. Signal-
averaged ECG abnormalities tended to be less frequent in
Group lA than Group IB, but none of the observed differ-
ences reached statistical significance. In contrast, both the
mean root mean square (RMS) voltage of the total QRS
complex and root mean square voltage of signals in the last
40 ms ofthe QRS complex (RMS40) were significantly higher
in Group lA than Group lB. No significant differences were
found between Groups lA and IB in terms of the prevalence
of complex ventricular arrhythmias (19% versus 20%, re-
spectively) or any of the index arrhythmias. Conversely, the
mean hourly number of ventricular premature complexes
was lower in Group lA than Group 1B (p < 0.01). In Group
lA, complex ventricular arrhythmias were seen in no pa-
tients with an abnormal signal-averaged ECG and in 21% of
patients with a normal signal-averaged ECG; in Group lB,
they were noted in 40% of patients with an abnormal
signal-averaged ECG and in 13% of patients with a normal
signal-averaged ECG (differences not significant).
Comparison of patients with or without patency of the
infarct-related coronary artery (Table 3). To assess if pa-
tency of the infarct-related artery, whether mediated by
thrombolysis or not, influenced the signal-averaged ECG
and the prevalence of complex ventricular arrhythmias, the
characteristics of 42 patients with patency of the infarct-
related artery (26 from Group lA and 16 from Group 2) were
compared with those of 33 patients with occlusion of the
infarct-related artery (20 from Group IB and 13 from Group
2). This analysis showed no significant differences in the
prevalence of abnormal signal-averaged ECG variables, al-
though a trend existed toward a lesser prevalence of abnor-
malities in the group with than in the group without patency
of the infarct-related artery. Moreover, the mean root mean
square voltage (RMS) of the total QRS complex and the last
40 ms (RMS40) ofthe QRS complex were significantly higher
in the former than the latter group, thus duplicating a finding
observed when comparing Groups lA and IB (patients with
or without patency of the infarct-related artery associated
with thrombolytic therapy). Similarly, no significant differ-
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Table 3. Characteristics of 75 Patients With or Without Patency of the Infarct-Related Coronary
Artery After Acute Myocardial Infarction
Patency of the Occlusion of the
Infarct·Related Infarct-Related
Coronary Artery Coronary Artery
(n = 42) (n = 33) p Value
Ambulatory ECG data
VPCs/h (n) 3.16±6.15 6.39 ± 7.00 <0.05
Frequent VPCs (%) 3 (7) 5 (15) NS
Polymorphic VPCs (%) 6 (14) 6 (18) NS
Couplets (%) 1(2) 3 (9) NS
Nonsustained VT (%) 5 (12) 3 (9) NS
Sustained VT (%) 0 I (3) NS
Complex ventricular arrhythmias (%) 7 (17) 6 (18) NS
Signal-averaged ECG data
QRS duration (ms) 99 ± 14 106 ± 18 NS
LAS40 (ms) 24 ± 10 29 ± 14 NS
RMS QRS (IlV) 140 ± 50 104 ± 38 <0.01
RMS40 (IlV) 72 ± 54 47 ± 27 <0.05
Prolonged QRS duration (%) 4 (10) 7 (21) NS
Prolonged LAS40 (%) 5 (12) 9 (27) NS
Late potentials (%) 5 (12) 8 (24) NS
Abnormal signal-averaged ECG (%) 6 (14) 9 (27) NS
I abnormal variable (%) 6 (14) 9 (27) NS
2 abnormal variables (%) 5 (12) 8 (24) NS
3 abnormal variables (%) 3 (7) 5 (15) NS
Abbreviations as in Table I.
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ences were found in the prevalence of complex ventricular
arrhythmias between patients with or without patency of the
infarct-related artery, although the mean hourly number of
ventricular premature complexes was lower (p < 0.05) in the
former group.
Discussion
Several large studies (16-25) have investigated the prev-
alence and significance of late potentials on the signal-
averaged ECG (16-20) and of complex ventricular arrhyth-
mias on the ambulatory ECG (21-25) after myocardial
infarction; however, most of these studies were performed
before the advent of the thrombolytic era (16.21-25), or the
number of patients subjected to thrombolysis was not re-
ported (17-20) or was too small to draw meaningful conclu-
sions (3,26). Thus, an assessment of the frequency of late
potentials and ventricular arrhythmias after thrombolysis
was overdue.
Thrombolysis and the signal-averaged EeG. Reports (3,4)
on the signal-averaged ECG in patients with or without
thrombolytic treatment have produced conflicting results.
Gang et al. (4) performed a signal-averaged ECG within 48 h
of admission in 44 patients with and 62 patients without
thrombolytic treatment and found abnormal variables in 2
(5%) and 14 (23%) patients, respectively. This difference was
statistically significant (p = 0.01). An abnormal signal-
averaged ECG was associated with future arrhythmic events
when observed in the late hospital period (6 to 30 days after
infarction) rather than in the early phase (0 to 5 days after
infarction) (27); thus, the findings of Gang et al. (4) may not
be relevant to long-term prognosis of postinfarction patients.
Furthermore, in their study, the signal-averaged ECG re-
peated before discharge remained abnormal in 2 (5%) pa-
tients with and in only II (18%) patients without thrombol-
ysis (difference not significant).
In our present study, we report the results of signal-
averaged ECGs performed 13 ± 2 days after myocardial
infarction in a series of 118 patients treated with or without
intravenous thrombolysis within 6 h of the onset of symp-
toms and with angiographic control of achieved reperfusion.
A threefold conclusion may be drawn from our data: I)
Thrombolysis favorably influenced some signal-averaged
ECG variables, namely, root mean square voltage of the
total QRS complex and root mean square voltage of the last
40 ms of the QRS complex. In fact, these indexes were
significantly higher in the presence than in the absence of
successful thrombolysis, possibly a reflection of reduced
loss of myocardial mass as a result of necrosis. Thus, they
may be helpful in estimating myocardial salvage after throm-
bolysis in a manner analogous to QRS scoring systems based
on the surface ECG (28,29). 2) Conversely, no significant
differences in the prevalence of an abnormal signal-averaged
ECG were observed between patients with or without
JACC Vol. 15, No.6
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thrombolysis, although there was a tendency toward fewer
abnormal signal-averaged ECG variables in the group with
than in the group without successful thrombolysis. 3) This
result was independent of the effect of thrombolysis on left
ventricular function because an abnormal signal-averaged
ECG was equally common in patients with or without
akinesia or dyskinesia in the infarcted area. The latter finding
duplicates that of Gomes et al. (30), who documented no
correlation between the signal-averaged ECG and left ven-
tricular ejection fraction and wall motion abnormalities in a
group of 50 postinfarction patients. It may be speculated that
late potentials arise from viable myocardium interspersed in
the infarct zone, showing delayed conduction, or from slow
activation in the infarct border zone (30,31). Thus, any
intervention to reduce the extent of myocardial infarction
and wall motion abnormalities may not be expected to
modify the substrate for late potentials on the signal-
averaged ECG.
Thrombolysis and ventricular arrhythmias, The immedi-
ate arrhythmogenic effects of thrombolysis have been well
recognized; in contrast, its delayed effects are less well
characterized (5,6). One study (5) suggested that ventricular
arrhythmias after thrombolysis-induced reperfusion were
limited to the early phase after treatment and were rare
before hospital discharge; however, a control group was not
available in this investigation. Theroux et al. (6) reported a
significant reduction in the number and frequency of ventric-
ular premature complexes/24 h in a large group of patients
treated with intravenous streptokinase, as compared with a
control group. On the contrary, the prevalence of ventricular
tachycardia was not altered by thrombolysis. The 24 h
ambulatory ECGs were performed after hospital discharge,
42 ± 72 days after the index infarction (6).
We, too, observed a decrease in the number of ventricu-
lar premature complexes after thrombolysis; however, we
were unable to show any changes in the prevalence of
complex ventricular arrhythmias. Differences in the time of
recording the ambulatory ECG and the definition of complex
ventricular arrhythmias may partially explain discrepancies
between our results and those of Theroux et al. (6). We
chose to record the ambulatory ECG 13 ± 2 days after
infarction because most studies (21-24) of the prognostic
significance of ventricular arrhythmias in survivors of myo~
cardial infarction derived their data from ambulatory ECGs
performed 10 to 11 days after the index event or before
discharge. Complex ventricular arrhythmias increased sub-
stantially on later recordings (9,27,32), but their prognostic
value remains to be established. Similarly, our definition of
frequent ventricular premature complexes was based on the
results of the Multicenter Post-Infarction Research Trial
(21), which demonstrated that ventricular premature com-
plexes carried a high risk for cardiac death when their
number was;::: 10th. The lack of a net antiarrhythmic efficacy
of thrombolytic therapy observed in our study is not surpris-
ing because the consequences of thrombolysis-mediated
reperfusion may not be uniform. In some cases, ventricular
arrhythmias may be improved because of reversal of ische-
mic damage, whereas in others, they may be exacerbated as
a result of enhanced heterogeneity of the infarct zone (33).
Limitations of the study. Our results may not be entirely
attributed to the use of thrombolytic agents. In fact, because
coronary angiography was performed in the late hospital
period, the possibility that, in some cases, patency of the
infarct-related artery was a spontaneous event rather than an
effect of thrombolysis must be considered. However, the
prevalence of an abnormal signal-averaged ECG and com-
plex ventricular arrhythmias did not seem to be related to the
patency of the infarct-related artery, whether it occurred
spontaneously or as an effect of thrombolysis.
Correlation between the signal-averaged ECG and complex
ventricular arrhythmias. Besides showing that late poten-
tials and complex ventricular arrhythmias recorded in the
postinfarction period are not influenced by thrombolysis, our
study highlighted the absence of a correlation between these
two phenomena. In fact, complex ventricular arrhythmias
were equally common in patients with or without an abnor-
mal signal-averaged ECG, both in the group with and in that
without thrombolytic therapy. Our finding confirms previous
contributions not focused on thrombolysis (9) and supports
the concept that late potentials on the signal-averaged ECG
and complex ventricular arrhythmias may reflect two dif-
ferent electrophysiologic substrates.
References
I. Ross AM. ed. Acute myocardial infarction: thrombolysis and angioplasty.
Circulation 1987;76(suppl 11):11-1-88.
2. Braunwald E. ed. Symposium on modem thrombolytic therapy. J Am
Coil CardioI1987;10:IB-104B.
3. Goedel-Meinen L. Hofmann M. Schmidt G. et al. The influence of
fibrinolytic therapy using streptokinase on the frequency and pattern of
ventricular late potentials. In: Hombach V, Hilger HH. Kennedy HL,
eds. Electrocardiography and Cardiac Drug Therapy. Dordrecht. The
Netherlands: Kluwer. 1989: 167-71.
4. Gang ES, Lew AS. Hong M. Wang FZ, Siebert CA, Peter T. Decreased
incidence of ventricular late potentials after successful thrombolytic
therapy for acute myocardial infarction. N Engl J Med 1989;321 :712-6.
5. Cercek B, Lew AS, Laramee P. Shah PK. Peter TC, Ganz w. Time
course and characteristics of ventricular arrhythmias after reperfusion in
acute myocardial infarction. Am J Cardiol 1987;60:214-8.
6. Theroux P, Morissette D. Juneau M, de Guise P. Pelletier G. Waters DD.
Influence offibrinolysis and percutaneous transluminal angioplasty on the
frequency of ventricular premature complexes. Am J Cardiol 1989;63:
797-801.
7. Simson MB. Use of signals in the terminal QRS complex to identify
patients with ventricular tachycardia after myocardial infarction. Circu-
lation 1981 ;64:235-42.
8. Caref EB. Turitto G, Ibrahim BB. Henkin R, EI-Sherif N. Role of
bandpass filters in optimizing the value of the signal-averaged electrocar-
diogram as a predictor of the results of programmed stimulation. Am J
Cardiol 1989;64: 16-26.
1276 TURITIO ET AL.
LATE POTENTIALS, ARRHYTHMIAS AND THROMBOLYSIS
lACC Vol. 15, No.6
May 1990:1270-6
9. Turitto G, Caref EB, Macina G, Fontaine JM, Ursell SN, EI-Sherif N.
Time course of ventricular arrhythmias and the signal-averaged electro-
cardiogram in the post-infarction period: a prospective study of correla-
tion. Br Heart J 1988;60:17-22.
10. Pollak SJ, Kertes PJ, Bredlau CE, Walter PF. Influence of left ventricular
function on signal-averaged late potentials in patients with coronary
artery disease with and without ventricular tachycardia. Am Heart J
1985;110:747-52.
II. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary
occlusion during the early hours of transmural myocardial infarction.
N Engl J Med 1980;303:897-902.
12. Khaja F, Walton JA Jr, Brymer JF, et al. Intracoronary fibrinolytic
therapy in acute myocardial infarction: report of a prospective random-
ized trial. N Engl J Med 1983;308:1305-11.
13. Anderson JL, Marshall HW, Bray BE, et al. A randomized trial of
intracoronary streptokinase in the treatment of acute myocardial infarc-
tion. N Engl J Med 1983;308:1312-8.
14. The TIMI Study Group. The Thrombolysis in Myocardial Infarction
(TIM!) Trial. Phase I findings. N Engl J Med 1985;312:932-6.
15. Elayda MA, Mathur VS, Hall RJ, Massumi GA, Garcia E, de Castro CM.
Collateral circulation in coronary artery disease. Am J Cardiol 1985:55:
58-60.
16. Breithardt G, Schwarzmayer J, Borggrefe M, Haerten K, Seipel L.
Prognostic significance of late ventricular potentials after acute myocar-
dial infarction. Eur Heart J 1983;4:487-95.
17. Denniss AR, Richards DA, Cody DV, et al. Prognostic significance of
ventricular tachycardia and fibrillation induced at programmed stimula-
tion and delayed potentials detected on the signal-averaged electrocardio-
grams of survivors of acute myocardial infarction. Circulation 1986;74:
731-45.
18. Kuchar DL, Thorburn CW, Sammel NL. Late potentials detected after
myocardial infarction: natural history and prognostic significance. Circu-
lation 1986;74:1280-9.
19. Gomes JA, Winters SL, Stewart D, Horowitz S, Milner M, Barreca P. A
new noninvasive index to predict sustained ventricular tachycardia and
sudden death in the first year after myocardial infarction: based on
signal-averaged electrocardiogram, radionuclide ejection fraction and
Holter monitoring. J Am CoIl CardioI1987;10:349-57.
20. Cripps T, Bennett ED, Camm AJ, Ward DE. High gain signal-averaged
electrocardiogram combined with 24 hour monitoring in patients early
after myocardial infarction for bedside prediction of arrhythmic events.
Br Heart J 1988;60:181-7.
21. The Multicenter Postinfarction Research Group. Risk stratification and
survival after myocardial infarction. N Engl J Med 1983;309:331-6.
22. Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM, and the
Multicenter Post-Infarction Research Group. The relationships among
ventricular arrhythmias, left ventricular dysfunction, and mortality in the
2 years after myocardial infarction. Circulation 1984;69:250-8.
23. MukhaIji J, Rude RE, Poole WK, et al. Risk factors for sudden death after
acute myocardial infarction: two-year follow-up. Am J Cardiol 1984;54:
31-6.
24. Bigger JT Jr, Fleiss JL, Rolnitzky LM, and the Multicenter Post-
Infarction Research Group. Prevalence, characteristics and significance
of ventricular tachycardia detected by 24-hour continuous electrocardio-
graphic recordings in the late hospital phase of acute myocardial infarc-
tion. Am J CardioI1986;58:1l51-60.
25. Kostis lB, Byington R, Friedman LM, Goldstein S, Furberg C, for the
BHAT Study Group. Prognostic significance of ventricular ectopic activ-
ity in survivors of acute myocardial infarction. J Am Coli Cardiol
1987;10:231-42.
26. McGuire M, Kuchar D, Ganis J, Sammel N, Thorburn C. Natural history
of late potentials in the first ten days after acute myocardial infarction and
relation to early ventricular arrhythmias. Am J CardioI1988;61:1l87-90.
27. EI-Sherif N, Ursell SN, Bekheit S, et al. Prognostic significance of the
signal-averaged ECG depends on the time of recording in the post-
infarction period. Am Heart J 1989;118:256-64.
28. Bren GB, Wasserman AG, Ross AM. The electrocardiogram in patients
undergoing thrombolysis for myocardial infarction. Circulation 1987;
76(suppl II):II-18-24.
29. Hogg KJ, Lees KR, Hornung RS, Howie CA, Dunn FG, Hillis WS.
Electrocardiographic evidence of myocardial salvage after thrombolysis
in acute myocardial infarction. Br Heart J 1989;61 :489-95.
30. Gomes JA, Horowitz SF, Millner M, Machac J, Winters SL, Barreca P.
Relation of late potentials to ejection fraction and wall motion abnormal-
ities in acute myocardial infarction. Am J Cardiol 1987;59: 1071-4.
31. EI-Sherif N, Gomes JAC, Restivo M, Mehra R. Late potentials and
arrhythmogenesis. PACE 1985;8:440-62.
32. Lichstein E, Morganroth J, Harrist R, Hubble E, for the BHAT Study
Group. Effect of propranolol on ventricular arrhythmia: the Beta-Blocker
Heart Attack Trial experience. Circulation 1983;67(suppl 1):1-5-10.
33. Ursell PC, Fenoglio 11 Jr. Structural basis of ventricular tachycardia. In:
Josephson ME, ed. Ventricular Tachycardia: Mechanisms and Manage-
ment. Mount Kisco, NY: Futura, 1982:151-78.
